Document Detail


Future possibilities for conducting clinical trials to test the efficacy of beta-blocker medications.
MedLine Citation:
PMID:  6133639     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Beta-blocker therapy apparently is important in the short- and long-term care of patients with myocardial infarction (MI). In the former, administration may reduce MI size, and in the latter, it promotes a statistically significant reduction in mortality. Since beta blockers exert a number of effects, it is still not known how the specific beneficial effects are mediated. Nevertheless, there is still a need to examine the effects of beta blockers, either singly or combined with other medications, on patients recovering from acute MI and as a late intervention. Specific attention must be directed to the older patient, those with moderate myocardial dysfunction, and those with life-threatening ventricular dysrhythmias. Each of these problems must be addressed by a well-designed, randomized clinical trial to ensure the best possible study design and the most accurate scientific outcome.
Authors:
J Naughton
Related Documents :
21619379 - Chronic heart failure: current evidence, challenges to therapy, and future directions.
15309209 - Blood pressure lowering, not vascular mechanism of action, is the primary determinant o...
21840879 - Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of ...
3010349 - Nutrient control of cardiac rate in the infant rat: alpha-adrenergic mechanisms.
22068609 - Multivessel percutaneous coronary intervention in patients with stable angina: a common...
22609869 - Focus on cardiac amyloidosis: a single-center experience with a long-term follow-up.
16172169 - Tachycardia-induced myocardial ischemia and diastolic dysfunction potentiate secretion ...
9174289 - Rapid atrial pacing for detecting provokable demand ischemia in anesthetized patients.
21619379 - Chronic heart failure: current evidence, challenges to therapy, and future directions.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Circulation     Volume:  67     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1983 Jun 
Date Detail:
Created Date:  1983-07-08     Completed Date:  1983-07-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  I106-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Adult
Aged
Clinical Trials as Topic / methods
Drug Therapy, Combination
Humans
Middle Aged
Myocardial Infarction / drug therapy*,  physiopathology
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial.
Next Document:  Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts...